MABBX
Price
$10.04
Change
-$0.01 (-0.10%)
Updated
Sep 20 closing price
VGSNX
Price
$21.46
Change
-$0.07 (-0.33%)
Updated
Sep 20 closing price
Ad is loading...

MABBX vs VGSNX

Header iconMABBX vs VGSNX Comparison
Open Charts MABBX vs VGSNXBanner chart's image
Morgan Stanley US Focus Real Estate C
Price$10.04
Change-$0.01 (-0.10%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.46
Change-$0.07 (-0.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MABBX vs VGSNX Comparison Chart
Loading...
FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. MABBX (5.34M). VGSNX pays higher dividends than MABBX: VGSNX (4.01) vs MABBX (0.89). MABBX was incepted earlier than VGSNX: MABBX (3 years) vs VGSNX (21 years). MABBX is a more actively managed with annual turnover of: 92.00 vs. VGSNX (9.00). MABBX has a lower initial minimum investment than VGSNX: MABBX (1000) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : 26.90 vs. MABBX (23.60).
MABBXVGSNXMABBX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence3 years21 years-
Gain YTD12.95613.45296%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.34M70.5B0%
Annual Yield % from dividends0.894.0122%
Returns for 1 year23.6026.9088%
Returns for 3 yearsN/A3.64-
Returns for 5 yearsN/A26.84-
Returns for 10 yearsN/A87.29-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPRX3.620.16
+4.62%
Kiora Pharmaceuticals Inc.
TRU101.141.17
+1.17%
TransUnion
SVRA4.440.01
+0.23%
Savara
KYMR46.44-0.86
-1.82%
Kymera Therapeutics
GALT2.71-0.06
-2.17%
Galectin Therapeutics